pb-201
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jul 15, 2019 (NCT03973515)
Timeline
Indications
Studied for
Mechanism of action
Glucokinase/Glucokinase regulatory protein activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05326490 | Phase 3 | May 30, 2022 | PegBio Co., Ltd. |
| NCT05102149 | Phase 3 | Dec 31, 2021 | PegBio Co., Ltd., Peking University |
| NCT03973515 | Phase 1 | Jul 15, 2019 | PegBio Co., Ltd., Peking University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PegBio Co., Ltd. | For profit | 3 | 3 | 2 | 2019 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2019 |
2 organizations
Page 1 / 1